Komodo Health is a healthcare technology company that partners with customers to improve patient care and reduce disease burden through data-driven insights and developer of a platform designed to deliver patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/22/2021 | Series E | $119.98MM | $xx.xx | $320.67B | Andreessen Horowitz, Casdin Capital, Iconiq Growth, Svb Capital, Tiger Global Management | |
Price per Share
$xx.xx
Shares Outstanding
2,352,388
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Casdin Capital, Iconiq Growth, Svb Capital, Tiger Global Management
|
||||||
01/11/2021 | Series D | $45.48MM | $xx.xx | $140.8B | Andreessen Horowitz, Felicis Ventures, IA Ventures, Iconiq Growth, Mckesson Ventures, Oak Hc/Ft | |
Price per Share
$xx.xx
Shares Outstanding
2,023,122
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Felicis Ventures, IA Ventures, Iconiq Growth, Mckesson Ventures, Oak Hc/Ft
|
||||||
01/08/2020 | Series C | $50MM | $xx.xx | $107.85B | Andreessen Horowitz, Felicis Ventures, IA Ventures, Oak Hc/Ft | |
Price per Share
$xx.xx
Shares Outstanding
2,894,621
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Felicis Ventures, IA Ventures, Oak Hc/Ft
|
||||||
04/22/2019 | Series B | $12.5MM | $xx.xx | $29.33B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,648,385
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.1x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/01/2016 | Series A | $7MM | $xx.xx | $5.92B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,311,213
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/03/2015 | Series Seed | $2.12MM | $xx.xx | $1.53B | Felicis Ventures, IA Ventures | |
Price per Share
$xx.xx
Shares Outstanding
8,500,128
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Felicis Ventures, IA Ventures
|